← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$388K

Shares

4,766

Price

$82

Filed

Dec 17

Insider

Name

LINK WILLIAM J PHD

Title

CIK

0001228684

Roles

Director

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

The sales were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.21 to $81.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.21 to $82.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $82.23 to $82.92. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The sales were not effected by a sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.21 to $81.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.21 to $81.79. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001228684-25-000005

Form Type

4

Issuer CIK

0001819790

LINK WILLIAM J PHD's History

Date Ticker Type Value
2025-12-15 TARS $408K
2025-12-15 TARS $516K
2025-12-15 TARS $95K
2025-12-15 TARS $458K
2025-12-15 TARS $388K
2025-09-16 TARS G $0
2025-09-08 TARS $1.5M
2025-06-13 TARS M
2025-06-13 TARS M $0
2025-06-12 TARS A $0

Other Insiders at TARS (90d)

Insider Bought Sold Last
Neervannan Seshadri
Chief Operating Officer
$200K 2026-03-20